N@N

PVA, FMS, CNMD, CPLP Expected To Be Higher Leading Up To Next Earnings Releases

^{Published on 2009-07-21 11:54:51, Last Modified on 2010-12-22 14:34:39 - WOPRAI}
 

July 22, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and July/August earnings reports. Penn Virginia (NYSE: PVA), Fresenius Medical Care (NYSE: FMS), CONMED Corp (NASDAQ: CNMD) and Capital Product Partners (NASDAQ: CPLP) are all expected to be higher leading up to their next earnings release. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act before its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go higher leading up to their next earnings release:

Symbol Company # of Reports Quarter Release Date

PVA Penn Virginia Corp. 12 quarters Q2 8/5/2009

FMS Fresenius Medical Care 12 quarters Q2 8/4/2009

CNMD CONMED Corporation 12 quarters Q2 7/30/2009

CPLP Capital Product Partner 12 quarters Q2 7/30/2009

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event. because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Penn Virginia Corporation (NYSE: PVA) engages in the development, exploration, and production of natural gas and oil in east Texas, the Mid-Continent, Appalachia, Mississippi, and the Gulf Coast regions of the United States. The company operates in three segments: Oil and Gas, Coal and Natural Resource Management, and Natural Gas Midstream. The Oil and Gas segment produces natural gas, condensate, and oil. As of December 31, 2008, it had proved natural gas and oil reserves of approximately 916 billion cubic feet, of which 82% were natural gas and 51% were proved developed. The Coal and Natural Resource Management segment primarily involves in the management and leasing of coal and natural resource properties, as well as the subsequent collection of royalties. It also engages in the other land management activities, such as the sale of standing timber; leasing of coal-related infrastructure facilities to certain lessees and end-user industrial plants; and coal transportation. As of December 31, 2008, this segment owned or controlled approximately 827 million tons of proven and probable coal reserves in Central and Northern Appalachia, the San Juan Basin, and the Illinois Basin. The Natural Gas Midstream segment provides natural gas processing, gathering, and other related services. As of December 31, 2008, this segment owned and operated 5 natural gas processing facilities, and approximately 4,069 miles of natural gas gathering pipelines located in Oklahoma and Texas. The company was founded in 1882 and is headquartered in Radnor, Pennsylvania with its additional offices in Oklahoma, Tennessee, Texas, and West Virginia.

Fresenius Medical Care North America (NYSE: FMS) is the continent's leading provider of renal dialysis products and services. With more than 20,000 employees, Fresenius Medical Care North America provides dialysis treatment, manufactures and distributes dialysis products, and performs diagnostic and laboratory testing for renal patients. Fresenius Medical Care North America is a subsidiary of Fresenius Medical Care AG & Co. KGaA, the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1,770,000 individuals worldwide. Through its network of 2,448 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 187,476 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and the New York Stock Exchange (FMS). For more information about Fresenius Medical Care visit the Companya�s website at www.fmc-ag.com.

CONMED Corporation (NASDAQ: CNMD), a medical technology company, provides surgical devices and equipment for minimally invasive procedures and monitoring. The companya�s products serve the clinical areas of arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring disposables, and endosurgery and endoscopic technologies. It offers arthroscopy products, including powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bioabsorbable implants and related disposable products, and fluid management systems, as well as video endoscopy products, and integrated operating room systems and equipment; powered surgical instruments used to perform orthopedic, arthroscopic, and other surgical procedures; and electrosurgical products comprising electrosurgical pencils and active electrodes, ground pads, generators, and the coagulation systems and smoke evacuation systems. CONMEDa�s patient care products comprise a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, ECG electrodes and cables, cardiac defibrillation and pacing pads, and blood pressure cuffs; surgical suction instruments and tubing products; and IV products for use in the critical care areas. It also offers endosurgical products, including clip appliers and laparoscopic instruments; and cutting trocars, suction/irrigation accessories, laparoscopic scissors, dissectors and graspers, active electrodes, insufflation needles, and linear cutters and staplers. The companya�s endoscopic technology products include forceps, accessories, bronchoscopy devices, dilatation, hemostasis, biliary devices, and polypectomy for the diagnosis and treatment of gastrointestinal and pulmonary disorders. CONMEDa�s products are used by surgeons and physicians in various specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The company was founded in 1970 and is headquartered in Utica, New York.

Capital Product Partners L.P. (NASDAQ: CPLP) owns double-hull medium-range product tankers worldwide. The company provides marine transportation services under medium to long-term time charters or bareboat charters. As of December 31, 2008, its fleet consisted of 18 vessels, including 15 MR tankers, 2 small product tankers, and 1 Suezmax crude oil tanker. These vessels are capable of carrying crude and refined oil products, such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals, such as ethanol. Capital GP L.L.C. serves as a general partner of the company. Capital Product Partners was founded in 2003 and is headquartered in Piraeus, Greece.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

One example from the SqueezeTrigger database is approximately 2.5 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641